AT ACC 16

CHICAGO (FRONTLINE MEDICAL NEWS) The largest-ever randomized trial of catheter ablation for atrial fibrillation ended in a draw, but there may be a clear winner for some patients.

Safety and 1-year efficacy of radiofrequency ablation and cryoballoon ablation were roughly 65% in both treatment arms of the 769-patient Fire and Ice trial.

However, in an interview at the annual meeting of the American College of Cardiology, principal investigator Dr. Karl-Heinz Kuck of Asklepios Klinik St. Georg, Hamburg, Germany, explains why the results are actually a victory for cryoablation.

bjancin@frontlinemedcom.com

Ads

You May Also Like

Researchers identify three distinct clinical-histologic-genetic subtypes in RA

FROM ARTHRITIS & RHEUMATOLOGY Researchers have identified three different synovial subtypes of rheumatoid arthritis ...

Doctors ask Congress to stop Part B drug payment test

AT HOUSE ENERGY AND COMMERCE HEALTH SUBCOMMITTEE HEARING WASHINGTON (FRONTLINE MEDICAL NEWS) – Physician ...